What opportunities do I have for earning American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points with the New England Journal of Medicine (NEJM)? Currently ...

We strive to produce fellows who are confident in their practice and well-prepared for ABIM: Hematology and Oncology board certification. We aspire to cultivate a culture of well-being, collegiality, ...

The American Board of Internal Medicine (ABIM) has revoked the board certification of two physicians involved in the Front ...

The American Board of Internal Medicine (ABIM) has created a training pathway for residents committed to academic physician-scientist careers. The ABIM Research Pathway (also known as a “short track”) ...

NYU Grossman School of Medicine's Oncology Two-Week Elective introduces students to the field of Medical Oncology ...

In 2009, he matched into the American Board of Internal Medicine Research Pathway in Cardiovascular Diseases ... He went on to complete his residency in Internal Medicine and fellowship in Hematology ...

Regardless of whether they operate in corporate, non-profit or academic settings, boards usually serve in one of three capacities: oversight, advisory or audit. While many associate boards with ...

Troy Wilson, Ph.D., J.D., President and CEO of Kura Oncology, expressed enthusiasm for Dr. Vasconcelles' addition to the board, citing his invaluable expertise as the company progresses with its ...

The article "Tumour mutational burden: clinical utility, challenges and emerging improvements" from J. Budczies et al. will be freely available while the October 2024 issue is featured on the ...

SAN DIEGO - Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company focusing on precision medicines for cancer treatment, announced today the appointment of Michael Vasconcelles, ...

WALTHAM, Mass - Mural Oncology plc (NASDAQ:MURA), a company specializing in engineered cytokine therapies for cancer treatment, has announced the addition of Sachiyo Minegishi to its board of ...

Dr. Vasconcelles is an accomplished biopharmaceutical executive with more than 25 years of oncology drug development experience and industry leadership. “On behalf of our Board and leadership ...